resveratrol has been researched along with Adenocarcinoma in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (3.08) | 18.2507 |
| 2000's | 23 (35.38) | 29.6817 |
| 2010's | 35 (53.85) | 24.3611 |
| 2020's | 5 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, XY; Dai, F; Hu, LM; Jin, XL; Kang, YF; Li, XZ; Li, Y; Liu, GY; Tang, JJ; Yang, J; Zhou, B | 1 |
| Chang, Q; Chen, J; Hao, Z; Li, J; Liang, P; Lu, J; Shi, J; Zeng, Z | 1 |
| Baheti, A; Bhargava, P; Chaugule, D; Gota, V; Jadhav, S; Jadhav, VK; Mandavkar, S; Mittra, I; Ostwal, V; Peelay, Z; Ramaswamy, A; Shinde, S; Srinivas, S; Tandel, H | 1 |
| Grau, L; Pujol, MD; Soucek, R | 1 |
| Gliszczyńska, A; Groborz, S; Kruszyńska, A; Lazar, Z; Ledesma-Amaro, R; Rapak, A; Rychlicka, M; Szczepańska, P | 1 |
| Gąsiorowski, K; Szafran, RG; Wiatrak, B | 1 |
| Bhatia, D; Shi, Q | 1 |
| Brighenti, F; Calani, L; Crozier, A; Del Rio, D; Fietta, E; Maggi, A; Meda, C; Ottonello, S; Ruotolo, R | 1 |
| Chen, C; Jiang, X; Zhang, Z; Zhao, W | 1 |
| Cai, JY; Liang, ZH; Yang, F; Yang, PH; Zhang, L | 1 |
| Cheng, HY; Fan, GH; Ma, JX; Qin, Q; Sun, XC; Wang, ZM; Xu, LP; Yang, X; Zhang, C | 1 |
| Moreno, JJ; Storniolo, CE | 1 |
| Lagergren, J; Lin, Y; Lu, Y; Yngve, A | 1 |
| Chen, C; Gu, S; Jiang, X; Zhang, Z | 3 |
| Dong, HM; Hong, T; Jiang, W; Lu, Y; Qiu, SX | 1 |
| Kolodziej, H; Lucas, IK | 1 |
| Chen, XY; Kong, QY; Li, C; Li, H; Liu, J; Wu, ML; Yang, B; Yao, YY; Zhang, P; Zhong, LX | 1 |
| Hayashi, K; Hori, Y; Joh, T; Kato, A; Kato, H; Kondo, H; Kuno, T; Miyabe, K; Mori, T; Naiki-Ito, A; Naitoh, I; Nakazawa, T; Nishi, Y; Ohara, H; Shimizu, S; Suzuki, S; Takahashi, S; Tsutsumi, M; Umemura, S; Yoshida, M | 1 |
| Wang, D; Wang, X; Zhao, Y | 1 |
| Kamholz, SL | 1 |
| Duessel, S; Ezekiel, UR; Heuertz, RM | 1 |
| Aquilano, K; Baldelli, S; Ciriolo, MR; Rotilio, G | 1 |
| Basaran, A; Cosan, D; Degirmenci, I; Gunes, HV; Soyocak, A | 1 |
| Chang, JC; Chiou, RY; Li, AF; Liao, HF; Weng, YL | 1 |
| Aggarwal, BB; Anand, P; Diagaradjane, P; Gelovani, J; Guha, S; Harikumar, KB; Krishnan, S; Kunnumakkara, AB; Pandey, MK; Sethi, G | 1 |
| Adhami, VM; Khan, N; Mukhtar, H | 1 |
| Han, Y; He, D; Jin, S; Qi, F; Wang, J; Zhang, Q | 1 |
| Charles, AL; Chen, WC; Chen, YH; Chen, YL; Chong, IW; Chou, SH; Hung, CY; Hwang, JJ; Lin, FY; Liu, PL; Ping, YH; Tsai, JR | 1 |
| Godevac, D; Juranić, Z; Matić, I; Savikin, K; Simonović, B; Simonović, M; Zizak, Z | 1 |
| Chen, Z; Gao, L; Jin, K; Jin, Y; Lou, G; Lou, Y; Yu, Y | 1 |
| Chang, L; Huang, N; Li, G; Lu, H; Zhang, H | 1 |
| Booth, TD; Brenner, DE; Britton, RG; Brown, K; Brown, VA; Crowell, JA; Gescher, AJ; Hemingway, D; Jones, DJ; Miller, AS; Patel, KR; Perloff, M; Steward, WP; West, KP | 1 |
| Basaran, A; Bayram, B; Cosan, DT; Degirmenci, I; Gunes, HV; Musmul, A; Soyocak, A | 1 |
| Basaran, A; Cosan, DT; Degirmenci, I; Gunes, HV; Sahin, FM; Soyocak, A | 1 |
| Białek, S; Bobrowska, B; Seweryn, M; Tokarz, A | 1 |
| Chen, T; Wang, X; Zhang, W | 2 |
| Couch, ME; Guttridge, DC; McKinney, KA; Rodríguez, JE; Shadfar, S; Weinstein, LJ; Willis, M; Yin, X | 1 |
| Bednarek, A; Fabianowska-Majewska, K; Salamé, P; Stefanska, B | 1 |
| Chitcholtan, K; Dann, JM; Evans, JJ; Guilford, P; Harris, G; Lewis, LK; Nagase, J; Sykes, PH; Welkamp, AA; Zwerus, R | 1 |
| Guo, C; Ke, A; Mo, W; Wang, F; Wang, X; Xu, L; Xu, X | 1 |
| Chen, T; Li, H; Qu, J; Wang, X | 1 |
| Huderson, AC; Myers, JN; Niaz, MS; Ramesh, A; Washington, MK | 1 |
| Cherkaoui Malki, M; Delmas, D; Jannin, B; Latruffe, N; Passilly-Degrace, P | 1 |
| Aggarwal, BB; Banerjee, S; Bueso-Ramos, C | 1 |
| Stein, J; Turchanowa, L; Wolter, F | 1 |
| Chadwick, LR; Mahady, GB; Pendland, SL | 1 |
| Brouillard, R; Chabert, P; Coelho, D; Fougerousse, A; Gossé, F; Launay, JF; Raul, F; Schneider, Y; Stutzmann, J | 1 |
| Attar, BM; Atten, MJ; Godoy-Romero, E; Holian, O; Milson, T; Zopel, M | 1 |
| Dabrosin, C; Garvin, S; Ollinger, K | 1 |
| Hirose, M; Ishii, Y; Kanki, K; Kitamura, Y; Kuroiwa, Y; Nishikawa, A; Umemura, T | 1 |
| Attar, BM; Atten, MJ; Erickson, J; Holian, O; Nayyar, S; Riles, WL | 1 |
| Lamartiniere, CA; Whitsett, TG | 1 |
| Azios, NG; Cammer, M; Cubano, LA; Dharmawardhane, SF; Harris, M; Krishnamoorthy, L | 1 |
| El-Naggar, AK; Gaur, A; Kondo, S; Kumar, R; Ohshiro, K; Rayala, SK; Vadlamudi, RK | 1 |
| Gossage, RA; Haddadi, A; Lai, R; Lavasanifar, A; Ma, Z; Molavi, O | 1 |
| Hsieh, TC; Wu, JM | 1 |
| Backer, JM; Burfeind, P; Darzynkiewicz, Z; Hsieh, TC; Laud, K; Traganos, F; Wu, JM | 1 |
| Fischer, H; Illek, B; Kurth, MJ; Lee, V; Lizarzaburu, ME; Nantz, MH | 1 |
| Mahyar-Roemer, M; Roemer, K | 1 |
| Bhat, KP; Pezzuto, JM | 1 |
| Attar, BM; Atten, MJ; Holian, O; Milson, T | 1 |
| Attar, BM; Atten, MJ; Holian, O; Wahid, S | 1 |
4 review(s) available for resveratrol and Adenocarcinoma
| Article | Year |
|---|---|
Wine, spirits and the lung: good, bad or indifferent?
Topics: Adenocarcinoma; Alcohol Drinking; Alcoholic Beverages; Alcoholism; Altitude Sickness; Antioxidants; Asthma; Female; Humans; Lung; Lung Neoplasms; Male; Pulmonary Disease, Chronic Obstructive; Pulmonary Edema; Respiratory Distress Syndrome; Resveratrol; Stilbenes; Sulfites; Wine | 2006 |
Apoptosis by dietary agents for prevention and treatment of prostate cancer.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Carotenoids; Catechin; Clinical Trials as Topic; Curcumin; Drug Screening Assays, Antitumor; Flavonoids; Flavonols; Genistein; Humans; Lycopene; Lythraceae; Male; Mice; Mice, Nude; Mice, Transgenic; Middle Aged; Neoplasm Proteins; Pentacyclic Triterpenes; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2010 |
Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Enzyme Activation; Fas Ligand Protein; Humans; Membrane Glycoproteins; Nitric Oxide Synthase; Protein Kinase C; Resveratrol; Stilbenes; Stomach Neoplasms | 2005 |
Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Administration, Oral; Adolescent; Age Factors; Animals; Antioxidants; Carcinogens; Cell Differentiation; Chemoprevention; Diet; Drug Administration Schedule; Drug Synergism; Estradiol; Female; Gene Expression Regulation; Genistein; Humans; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Molecular Structure; Pregnancy; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Resveratrol; Sexual Maturation; Soy Foods; Stilbenes; Wine | 2006 |
2 trial(s) available for resveratrol and Adenocarcinoma
| Article | Year |
|---|---|
A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study).
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Copper; Docetaxel; Female; Humans; Male; Middle Aged; Prospective Studies; Reactive Oxygen Species; Resveratrol; Stomach Neoplasms | 2022 |
Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cell Growth Processes; Colorectal Neoplasms; Combined Modality Therapy; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Resveratrol; Stilbenes | 2010 |
59 other study(ies) available for resveratrol and Adenocarcinoma
| Article | Year |
|---|---|
Synthesis and biological evaluation of hydroxylated 3-phenylcoumarins as antioxidants and antiproliferative agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Coumarins; DNA Damage; Drug Evaluation, Preclinical; Humans; Lung Neoplasms; Structure-Activity Relationship | 2011 |
Immunoprognostic model of lung adenocarcinoma and screening of sensitive drugs.
Topics: Adenocarcinoma; Carrier Proteins; Histocompatibility Antigens Class I; Humans; Lung; Lung Neoplasms; Male; Membrane Proteins; Methotrexate; Phenoxybenzamine; Resveratrol; RNA, Long Noncoding; RNA, Messenger; Tumor Microenvironment | 2022 |
Resveratrol derivatives: Synthesis and their biological activities.
Topics: Adenocarcinoma; Antineoplastic Agents; Antioxidants; Humans; Pancreatic Neoplasms; Resveratrol; Stilbenes | 2023 |
Studies on the Anticancer and Antioxidant Activities of Resveratrol and Long-Chain Fatty Acid Esters.
Topics: Adenocarcinoma; Antioxidants; Apoptosis; Esters; Fatty Acids; Humans; Resveratrol; Stilbenes; Superoxide Dismutase | 2023 |
Colorectal Adenocarcinoma Cell Culture in a Microfluidically Controlled Environment with a Static Molecular Gradient of Polyphenol.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Curcumin; Drug Screening Assays, Antitumor; Flavanones; Humans; Lab-On-A-Chip Devices; Microfluidic Analytical Techniques; Microfluidics; Neoplasms; Polyphenols; Resveratrol; Tumor Microenvironment | 2021 |
Resveratrol-Responsive CArG Elements from the Egr-1 Promoter for the Induction of GADD45α to Arrest the G2/M Transition.
Topics: A549 Cells; Adenocarcinoma; Cell Cycle Checkpoints; Cell Cycle Proteins; Early Growth Response Protein 1; Genes, Transgenic, Suicide; Genetic Therapy; Humans; Lung Neoplasms; Neoplasms; Nuclear Proteins; Response Elements; Resveratrol; Transcriptional Activation | 2019 |
Anti-estrogenic activity of a human resveratrol metabolite.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Clone Cells; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Glucosides; Glucuronides; Humans; MCF-7 Cells; Neoplasm Proteins; Nuclear Receptor Coactivator 2; Peptide Fragments; Phytoestrogens; Recombinant Proteins; Resveratrol; Stereoisomerism; Stilbenes; Sulfates | 2013 |
Dual role of resveratrol in modulation of genotoxicity induced by sodium arsenite via oxidative stress and apoptosis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Arsenites; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromosome Breakage; Comet Assay; DNA Damage; Glutathione; Humans; Lung Neoplasms; Micronuclei, Chromosome-Defective; Mutagens; Neoplastic Stem Cells; Osmolar Concentration; Oxidation-Reduction; Oxidative Stress; Resveratrol; Sodium Compounds; Stilbenes | 2013 |
In-situ detection of resveratrol inhibition effect on epidermal growth factor receptor of living MCF-7 cells by Atomic Force Microscopy.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Survival; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Immobilized Proteins; MCF-7 Cells; Microscopy, Atomic Force; Optical Imaging; Resveratrol; Stilbenes | 2014 |
Resveratrol inhibits oesophageal adenocarcinoma cell proliferation via AMP-activated protein kinase signaling.
Topics: Adenocarcinoma; AMP-Activated Protein Kinases; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p57; Esophageal Neoplasms; Humans; Proteasome Endopeptidase Complex; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; S-Phase Kinase-Associated Proteins; Signal Transduction; Stilbenes; Tumor Cells, Cultured; Ubiquitination | 2014 |
Resveratrol metabolites have an antiproliferative effect on intestinal epithelial cancer cells.
Topics: Adenocarcinoma; Antioxidants; Apoptosis; Cell Cycle; Cell Proliferation; Humans; Intestinal Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2012 |
A dietary pattern rich in lignans, quercetin and resveratrol decreases the risk of oesophageal cancer.
Topics: Adenocarcinoma; Aged; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Case-Control Studies; Diet; Esophageal Neoplasms; Esophagus; Feeding Behavior; Female; Humans; Lignans; Logistic Models; Male; Middle Aged; Odds Ratio; Plant Extracts; Quercetin; Resveratrol; Stilbenes | 2014 |
Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Synergism; Humans; Lung Neoplasms; Oxidative Stress; Oxides; Resveratrol; Stilbenes | 2015 |
Synthesis and cytotoxic activities of E-resveratrol derivatives.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Lung Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship; Uterine Cervical Neoplasms | 2015 |
Trans-Resveratrol Induces Apoptosis through ROS-Triggered Mitochondria-Dependent Pathways in A549 Human Lung Adenocarcinoma Epithelial Cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Caspase 8; Cell Line, Tumor; Cell Survival; Epithelial Cells; Fluoresceins; Humans; Lung Neoplasms; Mitochondria; Reactive Oxygen Species; Resveratrol; Stilbenes; Tetrazolium Salts; Thiazoles | 2015 |
PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Proliferation; Cell Survival; Cyclin D1; Female; Gene Expression; HeLa Cells; Humans; Inhibitor of Apoptosis Proteins; Molecular Chaperones; Phosphorylation; Protein Inhibitors of Activated STAT; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-myc; Resveratrol; RNA, Neoplasm; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Survivin; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2015 |
Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2.
Topics: Acetophenones; Adenocarcinoma; Animals; Anticarcinogenic Agents; Antioxidants; Blotting, Western; Carcinogenesis; Cell Line, Tumor; Cell Nucleus; Cell Survival; Chemoprevention; Cricetinae; Disease Models, Animal; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunohistochemistry; MAP Kinase Signaling System; Mesocricetus; Pancreatic Neoplasms; Phosphorylation; Resveratrol; Stilbenes | 2015 |
ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Synergism; Endoplasmic Reticulum Stress; Humans; Lung; Lung Neoplasms; Mitochondria; Oxides; Reactive Oxygen Species; Resveratrol; Stilbenes | 2016 |
[Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Caspase 3; Drug Synergism; Glutathione; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Oxidation-Reduction; Oxides; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2016 |
Effect and Mechanism of Resveratrol on the Apoptosis of Lung Adenocarcinoma Cell Line A549.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Cell Proliferation; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2015 |
Growth inhibition of human colon cancer cells by plant compounds.
Topics: Acrolein; Adenocarcinoma; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Piperidines; Plant Extracts; Resveratrol; Stilbenes | 2008 |
trans-Resveratrol inhibits H2O2-induced adenocarcinoma gastric cells proliferation via inactivation of MEK1/2-ERK1/2-c-Jun signalling axis.
Topics: Adenocarcinoma; Blotting, Western; Cell Proliferation; Enzyme Activation; Humans; Hydrogen Peroxide; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Resveratrol; Stilbenes; Stomach Neoplasms | 2009 |
The effects of resveratrol and tannic acid on apoptosis in colon adenocarcinoma cell line.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Cell Line, Tumor; Colonic Neoplasms; Fas-Associated Death Domain Protein; Humans; Resveratrol; Stilbenes; Tannins | 2009 |
Oral administration of resveratrol in suppression of pulmonary metastasis of BALB/c mice challenged with CT26 colorectal adenocarcinoma cells.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Immunologic Factors; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Recurrence, Local; Neoplasm Transplantation; Random Allocation; Resveratrol; Stilbenes; Survival Analysis; Tumor Burden | 2010 |
Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Proliferation; Cyclooxygenase 2; Deoxycytidine; Gemcitabine; Humans; Immunoenzyme Techniques; In Vitro Techniques; Male; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2010 |
Resveratrol protects against Cisplatin-induced cardiotoxicity by alleviating oxidative damage.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Cisplatin; Creatine Kinase; Free Radical Scavengers; Heart; Humans; L-Lactate Dehydrogenase; Lipid Peroxidation; Lung Neoplasms; Male; Malondialdehyde; Myocardium; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2009 |
Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Gene Silencing; Heme Oxygenase-1; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Neoplasm Invasiveness; NF-kappa B; Osmolar Concentration; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes | 2010 |
Cytotoxic effect of wine polyphenolic extracts and resveratrol against human carcinoma cells and normal peripheral blood mononuclear cells.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Survival; Cells, Cultured; Cytotoxins; Female; Flavonoids; Humans; Leukocytes, Mononuclear; Phenols; Polyphenols; Resveratrol; Stilbenes; Uterine Cervical Neoplasms; Wine | 2010 |
Anti-tumor effects of bakuchiol, an analogue of resveratrol, on human lung adenocarcinoma A549 cell line.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Line; Cell Line, Tumor; Cell Survival; Cells, Cultured; Humans; Inhibitory Concentration 50; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Osmolar Concentration; Phenols; Reactive Oxygen Species; Resveratrol; S Phase; Stilbenes; Time Factors; Tumor Suppressor Protein p53 | 2010 |
[Resveratrol inhibits EGF-induced invasion of human lung adenocarcinoma A549 cells].
Topics: Adenocarcinoma; Anticarcinogenic Agents; Blotting, Western; Cell Line, Tumor; Epidermal Growth Factor; Humans; Lung Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphatidylinositol 3-Kinases; Resveratrol; Signal Transduction; Stilbenes | 2010 |
Role of phenolic compounds in nitric oxide synthase activity in colon and breast adenocarcinoma.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Chemoprevention; Colonic Neoplasms; Female; Humans; Nitric Oxide Synthase; Phenols; Resveratrol; Stilbenes; Tannins | 2010 |
Effects of various agents on DNA fragmentation and telomerase enzyme activities in adenocarcinoma cell lines.
Topics: Adenocarcinoma; Analysis of Variance; Cell Line, Tumor; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Humans; Quercetin; Resveratrol; Stilbenes; Tamoxifen; Tannins; Telomerase | 2011 |
Effect of dietary supplementation on the prognostic value of urinary and serum 8-isoprostaglandin F2α in chemically-induced mammary carcinogenesis in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Biomarkers, Tumor; Carcinogens; Copper; Dietary Supplements; Dinoprost; Female; Genistein; Mammary Neoplasms, Experimental; Prognosis; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Zinc | 2011 |
Resveratrol induces mitochondria-mediated AIF and to a lesser extent caspase-9-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Apoptosis Inducing Factor; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Nucleus; Cell Survival; Enzyme Activation; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Protein Transport; Resveratrol; RNA Interference; Stilbenes | 2011 |
Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo.
Topics: Adenocarcinoma; Administration, Oral; Animals; Body Composition; Cachexia; Cell Line, Tumor; Dose-Response Relationship, Drug; Echocardiography; Female; Gene Expression Regulation, Enzymologic; Heart; Mice; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Myocardium; Neoplasm Transplantation; Random Allocation; Resveratrol; RNA, Messenger; Stilbenes; Transcription Factor RelA; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Weight Loss | 2011 |
Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells.
Topics: Adenocarcinoma; Adenosine; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cholecalciferol; Cyclin-Dependent Kinase Inhibitor p21; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Neoplasm Proteins; Promoter Regions, Genetic; PTEN Phosphohydrolase; Resveratrol; RNA, Messenger; Stilbenes; Tretinoin; Vitamins | 2012 |
Adrenomedullin interacts with VEGF in endometrial cancer and has varied modulation in tumours of different grades.
Topics: Adenocarcinoma; Adrenomedullin; Biomarkers, Tumor; Case-Control Studies; Catechin; Cell Line, Tumor; Cobalt; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Grading; Resveratrol; RNA, Messenger; Stilbenes; Up-Regulation; Vascular Endothelial Growth Factor A | 2012 |
Resveratrol induces apoptosis via a Bak-mediated intrinsic pathway in human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Inducing Factor; Apoptosis Regulatory Proteins; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Bcl-2-Like Protein 11; Caspase 9; Cell Line, Tumor; Cell Survival; Enzyme Activation; Humans; Lung Neoplasms; Membrane Proteins; Mitochondria; Proto-Oncogene Proteins; Resveratrol; Signal Transduction; Stilbenes | 2012 |
Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Hedgehog Proteins; Humans; Pancreatic Neoplasms; Resveratrol; Stilbenes | 2011 |
p38 inhibitor SB203580 sensitizes the resveratrol-induced apoptosis in human lung adenocarcinoma (A549) cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Survival; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Lung Neoplasms; Membrane Potential, Mitochondrial; p38 Mitogen-Activated Protein Kinases; Pyridines; Resveratrol; Stilbenes | 2012 |
Chemoprevention of benzo(a)pyrene-induced colon polyps in ApcMin mice by resveratrol.
Topics: Adenocarcinoma; Animals; Apoptosis; Benzo(a)pyrene; Cell Cycle; Colonic Neoplasms; Colonic Polyps; Male; Mice; Resveratrol; Stilbenes | 2013 |
Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells.
Topics: Adenocarcinoma; Anticarcinogenic Agents; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Colorectal Neoplasms; Cyclin A; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; DNA Replication; Enzyme Induction; Flow Cytometry; Gene Expression Regulation, Neoplastic; Growth Inhibitors; Humans; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Resveratrol; S Phase; Stilbenes; Tumor Cells, Cultured | 2002 |
Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Breast Neoplasms; Carcinogens; Cell Division; Cyclooxygenase 2; Female; Humans; Immunohistochemistry; Isoenzymes; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Membrane Proteins; NF-kappa B; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos.
Topics: Acetyltransferases; Adenocarcinoma; Adenosylmethionine Decarboxylase; Anticarcinogenic Agents; Base Sequence; Caco-2 Cells; Catechin; Colonic Neoplasms; DNA Primers; Gene Expression Regulation; Humans; Ornithine Decarboxylase; Polyamines; Proto-Oncogene Proteins c-fos; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes | 2003 |
Resveratrol and red wine extracts inhibit the growth of CagA+ strains of Helicobacter pylori in vitro.
Topics: Adenocarcinoma; Amoxicillin; Antigens, Bacterial; Antineoplastic Agents, Phytogenic; Bacterial Proteins; Chemoprevention; Gastrointestinal Neoplasms; Helicobacter pylori; Humans; Penicillins; Phenols; Plant Extracts; Resveratrol; Stilbenes; Wine | 2003 |
Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Caco-2 Cells; Cell Cycle; Cell Division; Colchicine; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gout Suppressants; Humans; Microtubules; Mitosis; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyamines; Polymers; Resveratrol; Stilbenes; Tubulin; Tubulin Modulators; Vinblastine | 2003 |
Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Resveratrol; Stilbenes; Transplantation, Heterologous; Vascular Endothelial Growth Factor A | 2006 |
Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Carcinogenicity Tests; Carcinogens; Cell Transformation, Neoplastic; Cricetinae; Cyclooxygenase 2; Diet; Injections, Subcutaneous; Isothiocyanates; Male; Membrane Proteins; Mesocricetus; Neoplasms, Experimental; Nitrosamines; Pancreatic Neoplasms; Resveratrol; Stilbenes; Sulfoxides; Thiocyanates | 2006 |
Resveratrol engages selective apoptotic signals in gastric adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Line, Tumor; Electron Transport Complex IV; Fas-Associated Death Domain Protein; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Stomach Neoplasms; Survivin; Tumor Suppressor Protein p53 | 2006 |
Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.
Topics: Actins; Adenocarcinoma; Breast Neoplasms; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cell Movement; Cytoskeleton; Dose-Response Relationship, Drug; Epidermal Growth Factor; Estradiol; Estrogens; Female; Genes, Dominant; Humans; Neoplasm Invasiveness; Neoplasms, Hormone-Dependent; Pseudopodia; rac GTP-Binding Proteins; Recombinant Fusion Proteins; Resveratrol; Stilbenes; Transfection | 2007 |
Identifying the estrogen receptor coactivator PELP1 in autophagosomes.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Autophagy; Cell Cycle; Cell Proliferation; Co-Repressor Proteins; Endosomal Sorting Complexes Required for Transport; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Lysosomes; Microtubule-Associated Proteins; Models, Biological; Phosphoproteins; Protein Transport; Receptors, Estrogen; Resveratrol; Salivary Gland Neoplasms; Stilbenes; Trans-Activators; Transcription Factors; Tumor Cells, Cultured | 2007 |
Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Biopolymers; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Estrogens; Female; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Resveratrol; STAT3 Transcription Factor; Stilbenes; Tubulin | 2008 |
Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.
Topics: Adenocarcinoma; Apoptosis; Cell Cycle; Cell Division; Flow Cytometry; G1 Phase; Gene Expression Regulation; Growth Inhibitors; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Resveratrol; S Phase; Stilbenes; Tumor Cells, Cultured | 1999 |
Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; Chemoprevention; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Metastasis; Resveratrol; Stilbenes; Transfection | 1999 |
Structural determinants for activation and block of CFTR-mediated chloride currents by apigenin.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adenocarcinoma; Anesthetics, Local; Apigenin; Biological Transport; Calcium Channel Blockers; Chlorides; Colforsin; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Flavonoids; Humans; Lidocaine; Lung; Lung Neoplasms; ortho-Aminobenzoates; Quinidine; Resveratrol; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
Topics: Adenocarcinoma; Alleles; Amino Acid Chloromethyl Ketones; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Benzothiazoles; Butyrates; Cisplatin; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Proteinase Inhibitors; Demecolcine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Neoplasm Proteins; Recombination, Genetic; Resveratrol; Stilbenes; Thiazoles; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Topics: Adenocarcinoma; Alkaline Phosphatase; Antigens, CD; Antineoplastic Agents, Phytogenic; CDC2-CDC28 Kinases; Cell Survival; Cyclin A; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Down-Regulation; Drug Interactions; Endometrial Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Gene Expression Regulation, Neoplastic; Humans; Integrin alpha1; Protein Serine-Threonine Kinases; Receptors, Estrogen; Receptors, Progesterone; Resveratrol; RNA, Messenger; S Phase; Stilbenes; Transcriptional Activation; Tumor Cells, Cultured | 2001 |
Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Apoptosis; Cell Cycle; Cell Division; DNA, Neoplasm; Humans; Mitogen-Activated Protein Kinases; Protein Kinase C; Resveratrol; Stilbenes; Stomach Neoplasms; Tumor Cells, Cultured | 2001 |
Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Division; DNA; Humans; Hydrogen Peroxide; Ionomycin; Ionophores; NADP; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Oxidants; Protein Kinase C; Reactive Oxygen Species; Resveratrol; Stilbenes; Stomach Neoplasms; Superoxides; Tumor Cells, Cultured | 2002 |